Literature DB >> 23508108

RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.

Jimena Druker1, Ana C Liberman, María Antunica-Noguerol, Juan Gerez, Marcelo Paez-Pereda, Theo Rein, Jorge A Iñiguez-Lluhí, Florian Holsboer, Eduardo Arzt.   

Abstract

Glucocorticoid receptor (GR) activity is modulated by posttranslational modifications, including phosphorylation, ubiquitination, and SUMOylation. The GR has three SUMOylation sites: lysine 297 (K297) and K313 in the N-terminal domain (NTD) and K721 within the ligand-binding domain. SUMOylation of the NTD sites mediates the negative effect of the synergy control motifs of GR on promoters with closely spaced GR binding sites. There is scarce evidence on the role of SUMO conjugation to K721 and its impact on GR transcriptional activity. We have previously shown that RSUME (RWD-containing SUMOylation enhancer) increases protein SUMOylation. We now demonstrate that RSUME interacts with the GR and increases its SUMOylation. RSUME regulates GR transcriptional activity and the expression of its endogenous target genes, FKBP51 and S100P. RSUME uncovers a positive role for the third SUMOylation site, K721, on GR-mediated transcription, demonstrating that GR SUMOylation acts positively in the presence of a SUMOylation enhancer. Both mutation of K721 and small interfering RNA-mediated RSUME knockdown diminish GRIP1 coactivator activity. RSUME, whose expression is induced under stress conditions, is a key factor in heat shock-induced GR SUMOylation. These results show that inhibitory and stimulatory SUMO sites are present in the GR and at higher SUMOylation levels the stimulatory one becomes dominant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23508108      PMCID: PMC3648064          DOI: 10.1128/MCB.01470-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

Review 1.  SUMO--nonclassical ubiquitin.

Authors:  F Melchior
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

2.  Systematic identification of novel protein domain families associated with nuclear functions.

Authors:  Tobias Doerks; Richard R Copley; Jörg Schultz; Chris P Ponting; Peer Bork
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

3.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

4.  Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors.

Authors:  Sunil Kaul; John A Blackford; Sehyung Cho; S Stoney Simons
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

5.  Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.

Authors:  A D Wallace; J A Cidlowski
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

7.  Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

Authors:  M H Tatham; E Jaffray; O A Vaughan; J M Desterro; C H Botting; J H Naismith; R T Hay
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

8.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

Authors:  H Poukka; U Karvonen; O A Janne; J J Palvimo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

Authors:  Randy K Bledsoe; Valerie G Montana; Thomas B Stanley; Chris J Delves; Christopher J Apolito; David D McKee; Thomas G Consler; Derek J Parks; Eugene L Stewart; Timothy M Willson; Millard H Lambert; John T Moore; Kenneth H Pearce; H Eric Xu
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

10.  The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  J Biol Chem       Date:  2002-06-11       Impact factor: 5.157

View more
  20 in total

Review 1.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 2.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

3.  The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.

Authors:  M Antunica-Noguerol; M L Budziñski; J Druker; N C Gassen; M C Sokn; S Senin; F Aprile-Garcia; F Holsboer; T Rein; A C Liberman; E Arzt
Journal:  Cell Death Differ       Date:  2016-05-13       Impact factor: 15.828

4.  Knockdown of RWD domain containing 3 inhibits the malignant phenotypes of glioblastoma cells via inhibition of phosphoinositide 3-kinase/protein kinase B signaling.

Authors:  Xiaofeng Chen; Weiping Kuang; Hongxing Huang; Bo Li; Yong Zhu; Bin Zhou; Lin Yan
Journal:  Exp Ther Med       Date:  2018-05-07       Impact factor: 2.447

5.  RSUME inhibits VHL and regulates its tumor suppressor function.

Authors:  J Gerez; L Tedesco; J J Bonfiglio; M Fuertes; M Barontini; S Silberstein; Y Wu; U Renner; M Páez-Pereda; F Holsboer; G K Stalla; E Arzt
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

6.  Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor.

Authors:  Jonas W Højfeldt; Osvaldo Cruz-Rodríguez; Yasuhiro Imaeda; Aaron R Van Dyke; James P Carolan; Anna K Mapp; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2014-01-01

Review 7.  The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease.

Authors:  Robert H Oakley; John A Cidlowski
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

Review 8.  Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

Authors:  Katherine A Leehy; Tarah M Regan Anderson; Andrea R Daniel; Carol A Lange; Julie H Ostrander
Journal:  J Mol Endocrinol       Date:  2016-02-01       Impact factor: 5.098

Review 9.  One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids.

Authors:  Diana Cruz-Topete; John A Cidlowski
Journal:  Neuroimmunomodulation       Date:  2014-09-12       Impact factor: 2.492

10.  Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.

Authors:  Feng Yang; Qi Ma; Zhijie Liu; Wenbo Li; Yuliang Tan; Chunyu Jin; Wubin Ma; Yiren Hu; Jia Shen; Kenneth A Ohgi; Francesca Telese; Wen Liu; Michael G Rosenfeld
Journal:  Mol Cell       Date:  2017-05-04       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.